Detalles de la búsqueda
1.
M-FISH evaluation of chromosome aberrations to examine for historical exposure to ionising radiation due to participation at British nuclear test sites.
J Radiol Prot
; 44(1)2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193305
2.
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Int J Cancer
; 143(4): 746-757, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29492969
3.
FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.
Breast Cancer Res Treat
; 170(3): 573-581, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29700676
4.
SOX11 promotes invasive growth and ductal carcinoma in situ progression.
J Pathol
; 243(2): 193-207, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28707729
5.
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
J Pathol
; 241(3): 362-374, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859259
6.
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
J Pathol
; 240(3): 315-328, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27512948
7.
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
Breast Cancer Res
; 18(1): 104, 2016 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27756439
8.
Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
J Pathol
; 226(3): 427-441, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22025283
9.
Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
EBioMedicine
; 88: 104436, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708693
10.
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.
Radiology
; 264(2): 581-9, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22700554
11.
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.
Cancer Res
; 81(4): 847-859, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509944
12.
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Nat Commun
; 11(1): 2662, 2020 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471999
13.
Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?
Radiology
; 249(2): 510-7, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18812560
14.
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 101(2): 309-315, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29559283
15.
Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers.
J Pathol Clin Res
; 4(3): 154-166, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659191
16.
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.
Mol Cancer Ther
; 17(1): 306-315, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133620
17.
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
J Pathol Clin Res
; 4(4): 250-261, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30062862
18.
Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations.
Int J Radiat Oncol Biol Phys
; 68(4): 1065-71, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17637389
19.
Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer.
Oncotarget
; 8(4): 6057-6066, 2017 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28002809
20.
Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
J Clin Oncol
; 23(24): 5560-7, 2005 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16110017